HomeVOR • NASDAQ
Vor Biopharma Inc
add
$1.06
19.10%
After Hours:(0.94%)-0.0100
$1.05
Closed: Jun 27, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 33.29M | 2.99% |
Net income | -32.49M | -5.46% |
Net profit margin | — | — |
Earnings per share | -0.26 | 42.22% |
EBITDA | -32.47M | -3.45% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 60.04M | -44.14% |
Total assets | 109.31M | -34.56% |
Total liabilities | 43.24M | -1.71% |
Total equity | 66.07M | — |
Shares outstanding | 124.96M | — |
Price to book | 1.68 | — |
Return on assets | -66.00% | — |
Return on capital | -73.87% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -32.49M | -5.46% |
Cash from operations | -31.07M | -1.97% |
Cash from investing | -230.00K | -100.52% |
Cash from financing | -606.00K | -731.25% |
Net change in cash | -31.90M | -334.50% |
Free cash flow | -20.45M | -4.91% |
Previous close
$0.89
Day range
$0.91 - $1.23
Year range
$0.13 - $1.80
Market cap
132.46M USD
Avg Volume
22.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
159